Bifidobacterium Breve - Klisyri (Tirbanibulin) Interaction
Herbal: Bifidobacterium Breve
Drug: Tirbanibulin
Brand names:
Klisyri
Medical Content Editor Dr. Brian Staiger, PharmD
Last updated
Dec 01, 2024
Interaction Details
There were no interactions found between Tirbanibulin and Bifidobacterium Breve. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.
Tirbanibulin Overview
-
Tirbanibulin is used to treat actinic keratosis (flat, scaly growths on the skin caused by too much sun exposure) on the face or scalp. Tirbanibulin is in a class of medications called microtubule inhibitors. It works by killing fast-growing cells such as the abnormal cells associated with actinic keratoses.
Bifidobacterium Breve - More Interactions
Bifidobacterium Breve interacts with 179 drugs
Interaction Rating Key
These severity listings are for informational use only. Never start, stop or otherwise change your therapy before speaking with your provider.
Major | The combined use of these agents is strongly discouraged as serious side effects or other negative outcomes could occur. |
Moderate | Use cautiously under the care of a healthcare professional or avoid this combination. A significant interaction or negative outcome could occur. |
Minor | Be aware that there is a chance of an interaction. Watch for warning signs of a potential interaction. |
Unknown | No interactions have been reported or no interaction data is currently available. |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.